|
|
TTD Drug ID:
DNC012885
Drug
Information |
Name | 4-Naphthalen-1-yl-5-piperidin-4-yl-isoxazol-3-ol | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C18H18N2O2/c21-18-16(17(22-20-18)13-8-10-19-11-9-13)15-7-3-5-1 2-4-1-2-6-14(12)15/h1-7,13,19H,8-11H2,(H,20,21) | InChIKey | WDMOSRJVOUIQMD-UHFFFAOYSA-N | Canonical SMILES | C1CNCCC1C2=C(C(=O)NO2)C3=CC=CC4=CC=CC=C43 | Target | GABA receptor alpha-1 subunit |  | Inhibitor | [1] | GABA receptor alpha-2 subunit |  | Inhibitor | [1] | GABA receptor beta-2 subunit |  | Inhibitor | [1] | GABA receptor gamma-2 subunit |  | Inhibitor | [1] | Ref 1 | J Med Chem. 2005 Jan 27;48(2):427-39.Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|